sync2brain

sync2brain operates at the intersection of neurotechnology, research tools, and medical devices. Its differentiating approach is to use real-time EEG analysis to time TMS according to detected brain states, rather than treating stimulation timing as independent of ongoing neural activity. The company’s bossdevice RESEARCH is described as a platform for EEG signal processing and oscillatory-pattern detection, while bossdevice MEDICAL is intended for investigational synchronized-stimulation work. This gives sync2brain a research-to-clinical development profile, with potential relevance to studies of neuropsychiatric conditions including stroke and depression. Likewise, there is no disclosed funding stage, scale, or commercial adoption data to support claims about market standing. The available evidence supports a differentiated technical focus—brain-state-contingent TMS enabled by real-time EEG—while leaving its competitive reach, regulatory progress, and clinical performance unquantified.

The research product, bossdevice RESEARCH, provides real-time EEG processing and detection of oscillatory patterns; bossdevice MEDICAL extends this approach to investigational TMS experiments and therapy. Preparation for CE certification is a stated development milestone, but no date or certification outcome is provided. Funding history, employee counts, and investor information are also unavailable, so growth cannot be quantified through capital raised, hiring, or team expansion. The company invites unsolicited applications via LinkedIn, indicating openness to applicants, but no specific role or hiring function is stated. Overall, the visible trajectory is defined by product and regulatory development rather than measurable commercial scaling; further dated product, certification, clinical, and hiring updates would be needed to identify inflection points.